Clofazimine: History and Perspectives

by G. N. Mozhokina, A. G. Samoylova
Published 2021-06-01

Nephrotoxic characteristics of anti-tuberculosis drugs

by G. N. Mozhokina, A. G. Samoylova, Z. A. Zangieva
Published 2019-11-01

The problem of neurotoxicity of drugs in the treatment of tuberculosis patients

by G. N. Mozhokina, A. G. Samoylova, I. A. Vasilyeva
Published 2020-11-01

THE ANTI-TUBERCULOSIS ANTIBIOTIC OF RIFAPENTINE: PERSPECTIVES OF CLINICAL USE

by A. G. Samoylova, E. I. Veselova, O. V. Lovacheva, G. D. Kaminsky
Published 2019-01-01

MUTATIONS OF MYCOBACTERIUM TUBERCULOSIS CAUSING RESISTANCE TO RIFAMPICIN AND ISONIAZID IN THE PATIENTS WITH DIFFERENT HIV STATUS

by E. I. Veselova, A. E. Panova, G. D. Kaminskiy, A. G. Samoylova
Published 2019-02-01

HIV reservoir in HIV patients

by E. I. Veselova, G. D. Kaminskiy, A. G. Samoylova, I. A. Vasilyeva
Published 2019-05-01

THE EFFECT OF DIFFERENT TB DRUGS AND ANTIMICROBIAL AGENTS ON THE EFFICIENCY OF TREATMENT OF TUBERCULOSIS PATIENTS WITH MULTIPLE DRUG RESISTANCE

by I. A. Vasilyeva, A. G. Samoylova, O. V. Lovacheva, L. N. Chernousova, T. R. Bagdasaryan
Published 2017-11-01

Short course treatment of pulmonary tuberculosis patients suffering from multiple drug resistance. The current situation and future perspectives

by A. E. Russkikh, D. M. Kutuzova, O. V. Lovacheva, A. G. Samoylova, I. A. Vasilyeva
Published 2021-01-01

Amplification of drug resistance against the background of inadequate chemotherapy for pulmonary tuberculosis

by I. A. Burmistrova, E. V. Vaniev, A. G. Samoylova, O. V. Lovacheva, I. A. Vasilyeva
Published 2019-09-01

IMPACT OF EXPRESS SUSCEPTIBILITY TESTING TO RIFAMPICIN OF M. TUBERCULOSIS ON CHEMOTHERAPY EFFICIENCY IN THOSE SUFFERING FROM MULTIPLE DRUG RESISTANT TUBERCULOSIS

by A. G. Samoylova, M. V. Burakova, I. A. Vasilieva, V. V. Lenskaya, E. V. Vaniev
Published 2016-09-01

Drug resistance of <i>M. tuberculosis</i> (historical aspects, current level of knowledge)

by I. A. Burmistrova, A. G. Samoylova, T. E. Tyulkova, E. V. Vaniev, G. S. Balasanyants, I. A. Vasilyeva
Published 2020-02-01

RANGES OF DRUG RESISTANCE OF THE PATHOGEN SENSITIVE TO RIFAMPICIN AND RESISTANT TO ISONIAZID IN PULMONARY TUBERCULOSIS PATIENTS

by I. A. Burmistrova, A. G. Samoylova, K. A. Glebov, A. E. Panova, T. S. Radina, I. A. Vasilyeva
Published 2019-01-01

Drug resistance pattern of <i>M. tuberculosis</i> in those who developed the disease after exposure to MDR/XDR pulmonary tuberculosis

by K. A. Glebov, V. A. Guseva, I. A. Burmistrova, O. V. Lovacheva, A. G. Samoylova, I. A. Vasilyeva
Published 2020-01-01

Novel coronavirus infection

by E. I. Veselova, A. E. Russkikh, G. D. Kaminskiy, O. V. Lovacheva, A. G. Samoylova, I. A. Vasilyeva
Published 2020-05-01

Virological and immunological efficacy of metabolically favorable antiretroviral therapy regimens in HIV patients who had no previous treatment

by E. I. Veselova, K. A. Kocharyan, O. V. Lovacheva, G. D. Kaminskiy, A. G. Samoylova, I. A. Vasilyeva
Published 2020-06-01

ECONOMIC FEASIBILITY OF NEW CHEMOTHERAPY REGIMENS FOR TREATMENT OF TUBERCULOSIS PATIENTS WITH EXTENSIVE DRUG RESISTANCE

by I. A. Vasilyeva, A. G. Samoylova, A. V. Rudakova, O. V. Lovacheva, K. A. Glebov, L. N. Chernousova
Published 2018-07-01